Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics (Premium)
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

HISAMITSU PHARMACEUTICAL CO INC Raises Mid-year Consolidated Outlook for FY 2013


Tuesday, 25 Sep 2012 10:30pm EDT 

HISAMITSU PHARMACEUTICAL CO INC announced that it has raised its mid-year consolidated outlook for revenue from JPY 71,100 million to JPY 71,900 million, operating profit from JPY 10,200 million to JPY 13,200 million, ordinary profit from JPY 13,400 million to JPY 16,400 million, net profit from JPY 7,900 million to JPY 9,300 million, and earnings per share from JPY 92.22 to JPY 108.56, for the fiscal year ending February 2013. The Company raised its mid-year consolidated outlook mainly due to the decrease in research and management costs. 

Company Quote

4140.0
0.0 +0.00%
30 Jul 2014